Skip to main content

Pediatrics

Pediatric Research

Overview

Our goal at the Center for Pediatric Research is to create the future of pediatric health care through research and data analysis to improve clinical performance and quality of care. We seek to increase the ability of AdventHealth for Children to become a leading children’s network and to extend the healing ministry of Christ.

AdventHealth for Children has over 135 highly skilled pediatric specialists covering more than 35 pediatric sub-specialties currently providing consultation services to the unit. Comprehensive sub-specialty care includes the Johns Hopkins Children’s Heart Surgery program, a Level IV Comprehensive Pediatric Epilepsy Center, Level III Neonatal Intensive Care Unit (NICU), Cancer and Blood Disorder specialty with a pediatric bone marrow transplant program, a Pediatric Liver Transplant program, and a Complex Care Clinic for patients with complex diagnoses. Interdisciplinary rounds occur every day on each patient. 

AdventHealth for Children has been recognized for excellence in nursing by being awarded Magnet status in 2012 and re-designation in 2016. AdventHealth for Children has been recognized by U.S. News & World Report as the Best Children’s Hospital for newborn care in Florida for the second year in a row.

Contact Information

Center for Pediatric Research

Areas of Focus

  • Asthma
  • Autism
  • Cardiology
  • Dermatology
  • Hematology
  • Hepatology
  • Neonatology 
  • Orthopedics
  • Sepsis (infections)
  • Pediatric obesity
  • Urology
  • Vaccines

Featured Clinical Trials

PEDS DIABETES

Icon for trial | PEDS DIABETES

This study is currently enrolling.

The purpose of this study is to determine how dulaglutide compares to placebo (a shot that does not contain any active medicine) in children and teens with type 2 diabetes who are treated with diet and exercise, and who may als ...

Hepatitis B

Icon for trial | Hepatitis B

This study is currently enrolling.

This study is being done to to evaluate the safety, tolerability and antiviral activity of tenofovir alafenamide (TAF) in pediatric patients with Hepatitis B (HBV). 

MET 42

Icon for trial | MET 42

This study is currently enrolling.

The main purpose of this study is to find out if the MenACYW conjugate vaccine is safe and protective of meningococcal disease in young children when given at the same time as the US recommended vaccine Menveo. Lab samples will ...

Meet the Team

Our Capabilities

  • 82 licensed beds in Women’s Hospital
  • 20 beds in Children’s Hospital
  • 2 neonatal transport teams 
  • 12 neonatologists and a dedicated interdisciplinary team (pharmacists, nutritionists, clinical social workers, nurse discharge coordinators, speech therapists, occupational/physical therapists, lactation consultants, and child life specialists)